Ergoteles LLC Seagen Inc. Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$127.59 - $203.08 $655,812 - $1.04 Million	-5,140 Reduced 22.47%	17,733 $3.59 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $1.6 Million - $1.89 Million	13,591 Added 146.42%	22,873 $2.94 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $1.26 Million - $1.67 Million	9,282 New	9,282 $1.27 Million
Q2 2022 Aug 12, 2022	SELL	$108.81 - $179.33 $525,552 - $866,163	-4,830 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$119.61 - $157.85 $577,716 - $762,415	4,830 New	4,830 $696,000
Q2 2021 Aug 12, 2021	SELL	$135.08 - $161.1 $4.7 Million - $5.6 Million	-34,771 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$137.51 - $190.8 $4.78 Million - $6.63 Million	34,771 New	34,771 $4.83 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.